Novel therapeutic agents for herpes simplex and cytomegaloviruses

Viruses from the human herpesvirus family are estimated to infect 90% of the adult population worldwide, and are responsible for lifelong debilitating and cogenital infections. Some members of this family are associated with human cancers and age-related cognitive decline.

Using our expertise in small molecule drug discovery and development in infectious disease, QMD is leveraging decades of HSV genetic and biochemical research to identify, characterize and exploit multiple drug targets of human herpesviruses.


Read more ...